Developer docs
API playgroundTry for free, no card

Search company profiles

No7

Full company profile

uuid000a155

Namestring
No7
Legal namestring
The Boots Company PLC
Company typeenum
Private
Founded yearint
1935
Descriptiontext

No7 is a British mass-market beauty brand founded in 1935 and wholly owned by The Boots Company PLC, itself part of Walgreens Boots Alliance. The brand sells skincare, makeup, and color cosmetics across more than a dozen sub-brands organized around skin concern or life stage — Future Renew (damage reversal), Restore & Renew, Protect & Perfect, Lift & Luminate, Hydraluminous+, Menopause Skincare, Good Intent, Derm Solutions, Radiance+, Laboratories, Pure Retinol, and Pro Artist makeup — priced from $9.99 entry-level products up to $42.99 specialty serums. Core formulation technology centers on proprietary peptide systems: Pepticology powers the Future Renew range, Matrixyl 3000+ anchors the Restore & Renew, Menopause, and Laboratories lines, a new Antioxidant Peptide Blend headlines Prime Forever, and Night Active Pepticology targets overnight repair. No7 markets clinically-validated efficacy (a 22,000-person study for Prime Forever; co-creation with 7,000 menopausal women for the Menopause range) and positions itself as accessible skincare with premium-leaning actives.

The brand's go-to-market is hybrid. In the UK it is distributed primarily through Boots' 2,000+ physical stores and Boots.com under a wholesale/concession-style arrangement tightly integrated with the Boots Advantage Card loyalty program. In the US, distribution runs through a dedicated direct-to-consumer site at us.no7beauty.com with localized pricing, USD-denominated Subscribe & Save (25-30% off recurring orders), a foundation shade finder, and a routine builder. The Australia market is served with localized product launches. The customer base is overwhelmingly female and concentrated in three core cohorts: women 40+ seeking anti-aging correction, women in perimenopause/menopause seeking hormonal skincare, and — newly via Prime Forever — women in their 30s seeking 'preservation' skincare ahead of visible aging.

Monetization combines three streams: one-time product purchase across unit pricing tiers (entry Good Intent, mid Restore & Renew, premium Future Renew and Laboratories), recurring subscription revenue via Subscribe & Save, and gift-set/bundle higher-AOV sales. No7 supports revenue with a content-driven blog covering ingredient education (peptides, retinol, vitamin C), a myNo7 Rewards loyalty program, a refer-a-friend mechanic ($10 credit each side), and student/essential-worker discount programs targeting younger affordability-constrained shoppers. A strategic partnership with Macmillan Cancer Support provides reputational differentiation. No7 reports operating status as active across UK, US, and Australia and is positioned within Boots as a flagship premium-accessible skincare label.

Short descriptiontext

No7 is a British beauty brand founded in 1935 and owned by The Boots Company PLC (Walgreens Boots Alliance), selling proprietary peptide-based skincare and cosmetics for women across anti-aging, menopause, and preservation categories via Boots retail and direct e-commerce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
skincare products, anti-aging cosmetics, peptide skincare, beauty brand, anti-wrinkle serums
Industry3 codes
1Treatment Skincare (Serums, Actives, Acne & Anti-aging)
CodeCRABAAABPrimaryYes
2Dermocosmetics & Medical-Grade Skincare
CodeCRABAAAFPrimaryNo
3Sensitive Skin & Barrier Repair
CodeCRABAAAGPrimaryNo
NAICS code2 codes
  • Cosmetics, Beauty Supplies, and Perfume Retailers45612
  • Health and Personal Care Retailers4561
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2840
Product category
Skincare and Cosmetics
Social media profiles4 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Physical and Digital Product Sales
TypeOne Time License
Description

No7 generates primary revenue through direct sales of skincare, makeup, and beauty products via Boots retail stores, Boots.com, and us.no7beauty.com. Products span multiple categories including serums, moisturizers, cleansers, eye creams, makeup, and specialty ranges for menopause and anti-aging.

us.no7beauty.com
2Subscribe & Save Program
TypeSubscription Recurring
Description

Recurring revenue through subscription model offering 25-30% savings on regular orders. Subscribers receive automatic deliveries with loyalty points (myNo7 Rewards), driving customer retention and predictable revenue.

us.no7beauty.com
3Gift Sets and Bundles
TypeOne Time License
Description

Revenue from curated product sets including The Mirror Skin Starter ($42), The Glass Skin Ritual ($84), The Complete Routine ($142), and Day/Night Cream Duos. Bundling drives higher average order value.

us.no7beauty.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Operations
Pricing details5 tiers
1Good Intent line - Entry-level skincare
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products priced from $9.99 to $24.99 in the US market. Line includes moisturizers, cleansers, eye creams, and lip masks targeting winter hydration and 'glass skin' trends.

us.no7beauty.com
2Future Renew range - Premium damage reversal
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Damage Reversal Serum and creams priced at $39.99 each. Night Serum at $39.99. Subscribe & Save reduces to approximately $28-31.99.

us.no7beauty.com
3Menopause Skincare range - Targeted solutions
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Instant Radiance Serum at $42.99, Firm & Bright Eye Concentrate at $29.99, Nourishing Overnight Cream at $37.99, Instant Cooling Mist at $19.99.

us.no7beauty.com
4Restore & Renew - Age-defying core range
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Day and Night Creams at $34.99, Face & Neck Serum at various sizes. Multi-piece skincare systems from $74.99.

us.no7beauty.com
5Subscription - Subscribe & Save
ModelSubscriptionBilling cadenceMonthly
Notes

25-30% savings on first and recurring orders. 30% off first order, 25% on recurring orders. Earns reward points.

us.no7beauty.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

No7 sells an extensive portfolio of branded skincare and cosmetics products — including serums, moisturizers, cleansers, eye creams, SPFs, sheet masks, and makeup — distributed across multiple sub-brands such as Future Renew, Restore & Renew, Protect & Perfect, Good Intent, Menopause Skincare, and Pro Artist. The brand combines proprietary peptide-based formulations (Matrixyl 3000+, Pepticology) with affordable pricing and is sold through Boots retail stores, Boots.com, and us.no7beauty.com. A Subscribe & Save subscription program (25–30% savings) and myNo7 Rewards loyalty program drive recurring revenue.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduces appearance of wrinkles by up to 5 years in 12 weeks (Matrixyl 3000+ clinical claims)
+4 more records
Product overview1 text field

No7 is a Boots-owned UK beauty brand established in 1935, offering an extensive skincare and cosmetics portfolio. The product offering is organized into multiple sub-brands including: Future Renew™ (damage reversal with proprietary Pepticology™ peptide technology), Restore & Renew (age-defying with collagen peptides and pro-retinol), Protect & Perfect (SPF protection), Lift & Luminate (brightening), Hydraluminous+ (hydration), Menopause Skincare (specialized for hormonal changes), Good Intent (affordable jelly-inspired skincare), Derm Solutions (dermatologist-approved for sensitive skin), Radiance+ (vitamin C brightening), Laboratories (concentrated boosters), Pure Retinol (treatment-focused), and Pro Artist (professional makeup). Individual products span serums, moisturizers, cleansers, eye creams, SPF, sheet masks, and makeup across these collections. The company emphasizes peptide technology (including Matrixyl 3000+™), clinical research, and targeted solutions for different life stages and skin concerns.

Product and service14 records
1Future Renew™
CategorySkincare (Anti-aging/Damage reversal)
Description

Damage reversal skincare range featuring proprietary Pepticology™ peptide technology to visibly reverse signs of skin damage. Includes serums, day/night creams, cleansers, and an SPF50 defense moisturizer for women targeting skin damage and visible aging.

2Restore & Renew
CategorySkincare (Anti-aging)
Description

Age-defying skincare collection targeting key signs of aging with collagen peptides, hyaluronic acid, and pro-retinol for firmer, brighter, more youthful-looking skin. Includes multi-action day cream SPF 30, night cream, face & neck serum, eye cream, and serum-boost sheet masks.

3Protect & Perfect
4Lift & Luminate
5Hydraluminous+
6Menopause Skincare
CategorySkincare (Menopause-specialized)
Description

Specialized skincare range co-created with over 7,000 menopausal women targeting visual signs of reduced estrogen including dullness, dryness, lack of firmness, and hot flashes. Features cooling applicators, hyaluronic acid, collagen peptides with Matrixyl 3000+, lipids, ceramides, and soy isoflavones.

7Good Intent
CategorySkincare (Affordable/Hydration)
Description

Affordable skincare line inspired by jelly beauty trends targeting the 'glass skin' trend with simplified, accessible products priced from $9.99, including Dew Bank Water Cream and Skin Sip Moisture Milk.

8Derm Solutions
9Radiance+
10Laboratories
11Pure Retinol
12Pro Artist
13Prime Forever
CategorySkincare (Preservation/Antioxidant)
Description

Future-proof skincare range featuring a new Antioxidant Peptide Blend developed from clinical research on over 22,000 people, designed to maintain skin health and slow visible aging. Includes cleanser, serum, moisturizer, SPF50 primer, and silicone eye patches.

14Subscribe & Save Program
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Boots partnership with Macmillan Cancer Support, with No7 products supporting women dealing with side effects of cancer treatment. The collaboration represents a significant CSR initiative, with Leanne Carden, Global Digital Director at No7, specifically citing the partnership as meaningful to customers dealing with cancer side effects.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

Olay is P&G's mass-market anti-aging skincare franchise focused on peptides, retinoids, and niacinamide at accessible price points. It is the closest direct competitor to No7 in mass anti-aging skincare, fighting for the same supermarket/drugstore shelf space and the same older-female consumer.

TypeDirect peer
Description

CeraVe is L'Oréal-owned dermocosmetics brand built on ceramides and clinical/dermatologist endorsement at mass-market price points. It directly competes with No7 Derm Solutions, Restore & Renew, and Hydraluminous+ on accessible, science-backed skincare positioning.

TypeBroad incumbent
Description

L'Oréal Paris is the global mass-market beauty incumbent with broad anti-aging, hydration, and skincare sub-brands (Revitalift, Hydra Genius). It competes with No7 across most mass channels globally and out-invests on marketing, but is much broader than the peptide-driven franchise No7 is known for.

TypeDirect peer
Description

Simple is a UK mass-market sensitive-skin cleanser and moisturizer brand historically sold through Boots alongside No7. They directly compete for the same Boots shelf real estate and similar sensitive-skin positioning, but Simple has a much narrower product scope than No7.

TypeEmerging player
Description

The Ordinary, owned by Estée Lauder, is an ingredient-led, low-price skincare brand that has reshaped the affordable-serum category. It overlaps with No7's serums and peptide positioning at lower price points and competes for the same younger, ingredient-savvy consumer in D2C channels.

TypeDirect peer
Description

La Roche-Posay is L'Oréal's dermocosmetics brand built around dermatological endorsement, sensitive skin, and clinical efficacy. It overlaps directly with No7 Derm Solutions and Menopause ranges on clinically-backed, dermatologist-validated skincare at mass-prestige price points.

TypeDirect peer
Description

Elizabeth Arden is a Revlon-owned mass-prestige skincare brand historically famous for anti-aging capsules (Ceramide Capsules) and Prevage. It competes with No7 Restore & Renew and Future Renew for the older anti-aging consumer, with similar department-store and drugstore distribution.

TypeBroad incumbent
Description

Estée Lauder Companies is a global prestige beauty conglomerate with broad anti-aging and clinical-skincare franchises (Estée Lauder, Clinique, The Ordinary). It overlaps with No7 on peptide/anti-aging skincare but with a more premium positioning and global retail footprint.

TypeOthers
Description

Boots' own-label skincare ranges (e.g., Boots Ingredients) are internal substitutes sold on the same Boots shelves as No7 at lower price points. They represent both No7's most important distribution partner and a direct competitor for the value-conscious Boots customer, creating both opportunity and risk.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

No7

Skincare and Cosmeticsus.no7beauty.com

No7 is a British beauty brand founded in 1935 and owned by The Boots Company PLC (Walgreens Boots Alliance), selling proprietary peptide-based skincare and cosmetics for women across anti-aging, menopause, and preservation categories via Boots retail and direct e-commerce.

What No7 does

No7 is a British mass-market beauty brand founded in 1935 and wholly owned by The Boots Company PLC, itself part of Walgreens Boots Alliance. The brand sells skincare, makeup, and color cosmetics across more than a dozen sub-brands organized around skin concern or life stage — Future Renew (damage reversal), Restore & Renew, Protect & Perfect, Lift & Luminate, Hydraluminous+, Menopause Skincare, Good Intent, Derm Solutions, Radiance+, Laboratories, Pure Retinol, and Pro Artist makeup — priced from $9.99 entry-level products up to $42.99 specialty serums. Core formulation technology centers on proprietary peptide systems: Pepticology powers the Future Renew range, Matrixyl 3000+ anchors the Restore & Renew, Menopause, and Laboratories lines, a new Antioxidant Peptide Blend headlines Prime Forever, and Night Active Pepticology targets overnight repair. No7 markets clinically-validated efficacy (a 22,000-person study for Prime Forever; co-creation with 7,000 menopausal women for the Menopause range) and positions itself as accessible skincare with premium-leaning actives.

The brand's go-to-market is hybrid. In the UK it is distributed primarily through Boots' 2,000+ physical stores and Boots.com under a wholesale/concession-style arrangement tightly integrated with the Boots Advantage Card loyalty program. In the US, distribution runs through a dedicated direct-to-consumer site at us.no7beauty.com with localized pricing, USD-denominated Subscribe & Save (25-30% off recurring orders), a foundation shade finder, and a routine builder. The Australia market is served with localized product launches. The customer base is overwhelmingly female and concentrated in three core cohorts: women 40+ seeking anti-aging correction, women in perimenopause/menopause seeking hormonal skincare, and — newly via Prime Forever — women in their 30s seeking 'preservation' skincare ahead of visible aging.

Monetization combines three streams: one-time product purchase across unit pricing tiers (entry Good Intent, mid Restore & Renew, premium Future Renew and Laboratories), recurring subscription revenue via Subscribe & Save, and gift-set/bundle higher-AOV sales. No7 supports revenue with a content-driven blog covering ingredient education (peptides, retinol, vitamin C), a myNo7 Rewards loyalty program, a refer-a-friend mechanic ($10 credit each side), and student/essential-worker discount programs targeting younger affordability-constrained shoppers. A strategic partnership with Macmillan Cancer Support provides reputational differentiation. No7 reports operating status as active across UK, US, and Australia and is positioned within Boots as a flagship premium-accessible skincare label.

No7 firmographics

Firmographics
Name
No7
Legal name
The Boots Company PLC
Website
https://us.no7beauty.com
Company type
Private
Founded year
1935
Operating status
Operating
Headcount range
51–100 employees
Short description
No7 is a British beauty brand founded in 1935 and owned by The Boots Company PLC (Walgreens Boots Alliance), selling proprietary peptide-based skincare and cosmetics for women across anti-aging, menopause, and preservation categories via Boots retail and direct e-commerce.
Ownership category
akta.pro rank

No7 industry classification

Industry
Product category
Skincare and Cosmetics
NAICS
Cosmetics, Beauty Supplies, and Perfume Retailers (45612), Health and Personal Care Retailers (4561)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)
akta.pro primary industry
Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)
akta.pro secondary industries
Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Sensitive Skin & Barrier Repair (CRABAAAG)

Keywords

  • Skincare products
  • Anti-aging cosmetics
  • Peptide skincare
  • Beauty brand
  • Anti-wrinkle serums

Where No7 is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

No7 business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Operations

Revenue model

  1. Physical and Digital Product Sales: No7 generates primary revenue through direct sales of skincare, makeup, and beauty products via Boots retail stores, Boots.com, and us.no7beauty.com. Products span multiple categories including serums, moisturizers, cleansers, eye creams, makeup, and specialty ranges for menopause and anti-aging.
  2. Subscribe & Save Program: Recurring revenue through subscription model offering 25-30% savings on regular orders. Subscribers receive automatic deliveries with loyalty points (myNo7 Rewards), driving customer retention and predictable revenue.
  3. Gift Sets and Bundles: Revenue from curated product sets including The Mirror Skin Starter ($42), The Glass Skin Ritual ($84), The Complete Routine ($142), and Day/Night Cream Duos. Bundling drives higher average order value.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goGood Intent line - Entry-level skincare
Unit PricingPay-as-you-goFuture Renew range - Premium damage reversal
Unit PricingPay-as-you-goMenopause Skincare range - Targeted solutions
Unit PricingPay-as-you-goRestore & Renew - Age-defying core range
SubscriptionMonthlySubscription - Subscribe & Save

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

No7 product offering

Product offering

Core offering

No7 sells an extensive portfolio of branded skincare and cosmetics products — including serums, moisturizers, cleansers, eye creams, SPFs, sheet masks, and makeup — distributed across multiple sub-brands such as Future Renew, Restore & Renew, Protect & Perfect, Good Intent, Menopause Skincare, and Pro Artist. The brand combines proprietary peptide-based formulations (Matrixyl 3000+, Pepticology) with affordable pricing and is sold through Boots retail stores, Boots.com, and us.no7beauty.com. A Subscribe & Save subscription program (25–30% savings) and myNo7 Rewards loyalty program drive recurring revenue.

Product overview

No7 is a Boots-owned UK beauty brand established in 1935, offering an extensive skincare and cosmetics portfolio. The product offering is organized into multiple sub-brands including: Future Renew™ (damage reversal with proprietary Pepticology™ peptide technology), Restore & Renew (age-defying with collagen peptides and pro-retinol), Protect & Perfect (SPF protection), Lift & Luminate (brightening), Hydraluminous+ (hydration), Menopause Skincare (specialized for hormonal changes), Good Intent (affordable jelly-inspired skincare), Derm Solutions (dermatologist-approved for sensitive skin), Radiance+ (vitamin C brightening), Laboratories (concentrated boosters), Pure Retinol (treatment-focused), and Pro Artist (professional makeup). Individual products span serums, moisturizers, cleansers, eye creams, SPF, sheet masks, and makeup across these collections. The company emphasizes peptide technology (including Matrixyl 3000+™), clinical research, and targeted solutions for different life stages and skin concerns.

Differentiator

Problem solved

Functional benefit

Products and services

  • Future Renew™ Damage reversal skincare range featuring proprietary Pepticology™ peptide technology to visibly reverse signs of skin damage. Includes serums, day/night creams, cleansers, and an SPF50 defense moisturizer for women targeting skin damage and visible aging.
  • Restore & Renew Age-defying skincare collection targeting key signs of aging with collagen peptides, hyaluronic acid, and pro-retinol for firmer, brighter, more youthful-looking skin. Includes multi-action day cream SPF 30, night cream, face & neck serum, eye cream, and serum-boost sheet masks.
  • Protect & Perfect
  • Lift & Luminate
  • Hydraluminous+
  • Menopause Skincare Specialized skincare range co-created with over 7,000 menopausal women targeting visual signs of reduced estrogen including dullness, dryness, lack of firmness, and hot flashes. Features cooling applicators, hyaluronic acid, collagen peptides with Matrixyl 3000+, lipids, ceramides, and soy isoflavones.
  • Good Intent Affordable skincare line inspired by jelly beauty trends targeting the 'glass skin' trend with simplified, accessible products priced from $9.99, including Dew Bank Water Cream and Skin Sip Moisture Milk.
  • Derm Solutions
  • Radiance+
  • Laboratories
  • Pure Retinol
  • Pro Artist
  • Prime Forever Future-proof skincare range featuring a new Antioxidant Peptide Blend developed from clinical research on over 22,000 people, designed to maintain skin health and slow visible aging. Includes cleanser, serum, moisturizer, SPF50 primer, and silicone eye patches.
  • Subscribe & Save Program

Quantifiable outcome

  • Reduces appearance of wrinkles by up to 5 years in 12 weeks (Matrixyl 3000+ clinical claims)
  • +4 more outcomes

Companies that use No7

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles1 record

No7 technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

No7 partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Macmillan Cancer SupportcoreStrategic or Co-development PartnerBoots partnership with Macmillan Cancer Support, with No7 products supporting women dealing with side effects of cancer treatment. The collaboration represents a significant CSR initiative, with Leanne Carden, Global Digital Director at No7, specifically citing the partnership as meaningful to customers dealing with cancer side effects.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

No7 competitors and assessment

Company assessment

Direct peers

  • Olay: Olay is P&G's mass-market anti-aging skincare franchise focused on peptides, retinoids, and niacinamide at accessible price points. It is the closest direct competitor to No7 in mass anti-aging skincare, fighting for the same supermarket/drugstore shelf space and the same older-female consumer.
  • CeraVe: CeraVe is L'Oréal-owned dermocosmetics brand built on ceramides and clinical/dermatologist endorsement at mass-market price points. It directly competes with No7 Derm Solutions, Restore & Renew, and Hydraluminous+ on accessible, science-backed skincare positioning.
  • Simple Skincare: Simple is a UK mass-market sensitive-skin cleanser and moisturizer brand historically sold through Boots alongside No7. They directly compete for the same Boots shelf real estate and similar sensitive-skin positioning, but Simple has a much narrower product scope than No7.
  • La Roche-Posay: La Roche-Posay is L'Oréal's dermocosmetics brand built around dermatological endorsement, sensitive skin, and clinical efficacy. It overlaps directly with No7 Derm Solutions and Menopause ranges on clinically-backed, dermatologist-validated skincare at mass-prestige price points.
  • Elizabeth Arden: Elizabeth Arden is a Revlon-owned mass-prestige skincare brand historically famous for anti-aging capsules (Ceramide Capsules) and Prevage. It competes with No7 Restore & Renew and Future Renew for the older anti-aging consumer, with similar department-store and drugstore distribution.

Broad incumbents

  • L'Oréal Paris: L'Oréal Paris is the global mass-market beauty incumbent with broad anti-aging, hydration, and skincare sub-brands (Revitalift, Hydra Genius). It competes with No7 across most mass channels globally and out-invests on marketing, but is much broader than the peptide-driven franchise No7 is known for.
  • Estée Lauder: Estée Lauder Companies is a global prestige beauty conglomerate with broad anti-aging and clinical-skincare franchises (Estée Lauder, Clinique, The Ordinary). It overlaps with No7 on peptide/anti-aging skincare but with a more premium positioning and global retail footprint.

Emerging players

  • The Ordinary (DECIEM): The Ordinary, owned by Estée Lauder, is an ingredient-led, low-price skincare brand that has reshaped the affordable-serum category. It overlaps with No7's serums and peptide positioning at lower price points and competes for the same younger, ingredient-savvy consumer in D2C channels.

Others

  • Boots Ingredients / Boots own-label skincare: Boots' own-label skincare ranges (e.g., Boots Ingredients) are internal substitutes sold on the same Boots shelves as No7 at lower price points. They represent both No7's most important distribution partner and a direct competitor for the value-conscious Boots customer, creating both opportunity and risk.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

No7 social profiles

Digital presence

No7 compliance and trust

Trust signal

Compliance3 records

No7 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

No7 leadership team

Management profile

Number of profiles

Profiles6 records

No7 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

No7 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about No7

What does No7 do?

No7 sells an extensive portfolio of branded skincare and cosmetics products — including serums, moisturizers, cleansers, eye creams, SPFs, sheet masks, and makeup — distributed across multiple sub-brands such as Future Renew, Restore & Renew, Protect & Perfect, Good Intent, Menopause Skincare, and Pro Artist. The brand combines proprietary peptide-based formulations (Matrixyl 3000+, Pepticology) with affordable pricing and is sold through Boots retail stores, Boots.com, and us.no7beauty.com. A Subscribe & Save subscription program (25–30% savings) and myNo7 Rewards loyalty program drive recurring revenue.

Is No7 a public or private company?

No7 is a private company. It is classified as corporate owned and is currently operating.

When was No7 founded?

No7 was founded in 1935. It employs 51 to 100 people.

Where is No7 based?

No7 is headquartered in New York, United States, in the North America region.

How does No7 make money?

Three revenue lines are on record. Physical and Digital Product Sales are the primary driver. The others are subscribe & Save Program and gift Sets and Bundles.

Who are No7's main competitors?

Direct peers on record are Olay, CeraVe, Simple Skincare, La Roche-Posay and Elizabeth Arden. Broad incumbents are L'Oréal Paris and Estée Lauder. The Ordinary (DECIEM) is listed as an emerging player. Boots Ingredients / Boots own-label skincare is listed as an others.

Does No7 have an API?

No public API is recorded for No7.

What industry is No7 in?

No7's product category is Skincare and Cosmetics. Its primary akta.pro industry code is CRABAAAB, Treatment Skincare (Serums, Actives, Acne & Anti-aging), with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 45612 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Page SixDolores Catania spills her summer essentials, from anti-frizz spray to bedazzled water bottlesDolores Catania shared her summer beauty and wellness essentials, including Dermalogica, Unite anti-frizz mist, and No7 cream, after her son's wedding in Portugal. She also recommended a silk pillowcase and a bedazzled water bottle with collagen powder. The products are part of her routine for staying polished and hydrated.Refinery29What Is “Skin Preservation,” & Why Is It Everywhere Right Now?A beauty editorial reviews No7's new Prime Forever collection, a four-piece skincare routine positioned around the concept of 'skin preservation' — proactively maintaining skin health before visible aging accelerates. The article explores how this emerging trend differs from traditional anti-aging, emphasizing proactive skincare routines over reactive treatments. The reviewer tested all four products (cleanser, serum, moisturizer, and SPF 50 primer), praising their textures and accessibility (priced $20-$39), while noting that long-term results will require years to fully appreciate.Refinery29Get "Glass Skin" This Winter With These No7 ProductsThe UK beauty brand No7 has released a new line of 12 "Good Intent" skincare products priced from $9.99, targeting winter hydration needs and the popular "glass skin" trend. The product range takes inspiration from jelly beauty trends and prioritizes affordability and simplicity. The article appears to be an editorial product recommendation from Refinery29 Australia.HELLO!At 36 I feel ignored by the beauty industryAn opinion piece by a beauty writer argues that women in their 30s are systematically underserved by the skincare industry, which prioritises Gen Z consumers with acne and barrier concerns alongside menopausal women seeking anti-ageing solutions, leaving thirtysomethings without targeted products. The article identifies a new emerging category called 'preservation skincare', designed to maintain skin at its current state rather than correct problems or reverse ageing, with No7 launching its Prime Forever range specifically for this demographic. The piece highlights No7's Prime Forever launch, where a product reportedly sold every three seconds on launch day at Boots, alongside Neutrogena's Collagen Bank range, as evidence of industry recognition of this underserved market segment.YahooNo7 just launched its first-ever skincare range designed to future-proof the health of your skinNo7, the Boots-owned beauty brand, has launched its first "Prime Forever" skincare range, consisting of five products (cleanser, serum, moisturizer, SPF50 primer, and silicone eye patches) priced from £17.95, featuring a new Antioxidant Peptide blend developed after clinical research on over 22,000 people. The range is designed to slow visible skin ageing, which No7 says accelerates by up to 50% from one's 30s onward. A consultant dermatologist has endorsed the launch, calling the broad-spectrum antioxidant blend a "new gold standard for accessible antioxidant technology."Woman and Home MagazineNo7 just launched its first-ever skincare range designed to future-proof the health of your skinThe Boots-owned beauty brand No7 has launched its first-ever Prime Forever skincare range, consisting of five products designed to slow visible skin ageing based on clinical research involving over 22,000 people.Boots-UkNo7 launches skin preservation collection with patent-pending technology targeting invisible damageNo7, the UK's number one skincare brand, has launched the Prime Forever collection, its first product line dedicated to skin preservation—a proactive approach to protecting skin from damage before it becomes visible. The launch is based on a company-conducted study of over 22,000 participants which identified the 30s as the critical decade for skin ageing, with visible ageing accelerating by up to 50% during this period. The collection features a patent-pending Antioxidant Peptide blend combining broad-spectrum antioxidants and super peptides to target invisible damage beneath the skin's surface.PrimaNo7 expands Future Renew into body care, with prices starting at £18No7 has expanded its Future Renew skincare range into body care with three new products — a neck and décolletage serum at £43, a body serum at £33, and a hand cream at £18 — all using the brand's proprietary peptide technology. The body serum reportedly sold out at No7 online within a day of launching, suggesting strong early consumer demand. The products are available exclusively in store and online at Boots.Good HousekeepingA hand-lift in a tube! No7’s anti-ageing bestseller has a body range – and one product has us soldNo7 has expanded its Future Renew skincare range with new products targeting areas below the neck, including a neck and décolleté serum, a hand cream with SPF15, and a body serum. The new products aim to improve signs of aging such as wrinkles, loss of firmness, and uneven skin tone, with the hand cream also providing immediate visible benefits. The article highlights the scientific backing of the range and personal testimonials of effectiveness.GraziaA Review: No7 Future Renew Damage Reversal Body RangeBeauty brand No7 has launched three new products in its Future Renew Damage Reversal body care range, including a body serum, hand cream, and neck & décolletage serum, alongside new research revealing that 59% of UK women aged 40–65 feel they have 'forgotten themselves'. The review, authored by a beauty editor, evaluates all three products, awarding each a 5.0 expert rating while describing the textures and application experience positively. The article frames the product launch within a broader personal essay about aging and self-care rituals, positioning the range as part of a movement encouraging women to reconnect with themselves.